COX-2 expression and significance in patients with nasopharyngeal carcinoma
Dongyun Li
Abstract
Dongyun Li
Abstract
OBJECTIVE:To investigate the biological significance of COX-2 expression in nasopharyngeal carcinoma.METHODS:The expression of COX-2 was detected in 90 nasopharyngeal carcinoma tissues and 22 nasopharyngitis tissues by SP immunohistochemical method.RESULT:The positive expression rate of COX-2 protein in nasopharyngeal carcinoma tissues was 67.78%(61/90), and 36.36%(8/22) in nasopharyngitis tissues, and the difference was significant (χ2 =7.38,P=0.01). The ratio of COX-2 expression was 83.8% in patients with the lymth nodes stage of N2 and N3,which was significantly different from that of 54.2% in N0 and N1 (χ2=10.23,P=0.017). The expression of COX-2 gene was not related to age,gender, the clinical stages, T stages and distant metastasis of nasopharyngeal carcinoma patients treated with radiotherapy(P0.05).CONCLUSIONS: There is a high expression of COX-2 in nasopharyngeal carcinoma tissues, which might be an important event in the pathogenesis and progression of nasopharyngeal carcinoma, but it can not be a target of evaluating primary efficacy of nasopharyngeal carcinoma patients treated with radiotherapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To investigate the biological significance of COX-2 expression in nasopharyngeal carcinoma.METHODS:The expression of COX-2 was detected in 90 nasopharyngeal carcinoma tissues and 22 nasopharyngitis tissues by SP immunohistochemical method.RESULT:The positive expression rate of COX-2 protein in nasopharyngeal carcinoma tissues was 67.78%(61/90), and 36.36%(8/22) in nasopharyngitis tissues, and the difference was significant (χ2 =7.38,P=0.01). The ratio of COX-2 expression was 83.8% in patients with the lymth nodes stage of N2 and N3,which was significantly different from that of 54.2% in N0 and N1 (χ2=10.23,P=0.017). The expression of COX-2 gene was not related to age,gender, the clinical stages, T stages and distant metastasis of nasopharyngeal carcinoma patients treated with radiotherapy(P0.05).CONCLUSIONS: There is a high expression of COX-2 in nasopharyngeal carcinoma tissues, which might be an important event in the pathogenesis and progression of nasopharyngeal carcinoma, but it can not be a target of evaluating primary efficacy of nasopharyngeal carcinoma patients treated with radiotherapy.
Key concepts: Nasopharyngeal carcinoma, Immunohistochemistry, Stage (stratigraphy), Medicine, Radiation therapy, Pathogenesis, Carcinoma, Clinical significance